| Wojakowski, Wojciech |
HighFLO, NCT04888247: Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve |
|
|
| Recruiting | N/A | 30 | Europe, RoW | CLARITY | HighLife SAS | Mitral Regurgitation | 12/24 | 02/30 | | |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
NCT04029363: Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk |
|
|
| Recruiting | N/A | 120 | Europe, RoW | HighLife Transcatheter Mitral Valve Replacement | HighLife SAS, ICON plc | Mitral Regurgitation | 03/24 | 06/29 | | |
EMPIRE-II, NCT05804903: Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis |
|
|
| Recruiting | N/A | 177 | Europe | (ALLEGRA Plus Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis | NVT GmbH | Transcatheter Aortic Valve Implantation | 03/25 | 12/29 | | |
| Webster, Mark |
NCT05033964: The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions |
|
|
| Active, not recruiting | 2 | 200 | Europe, RoW | Percutaneous Coronary Intervention with drug eluting stents | Elixir Medical Corporation | Coronary Artery Disease | 12/22 | 03/26 | | |
NCT04585308: transShield Embolic Protection System Feasibility Study |
|
|
| Completed | N/A | 28 | RoW | transShield Embolic Protection System | TransAortic Medical, Inc. | Aortic Stenosis | 03/23 | 03/23 | | |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
| Legutko, Jacek |
| Completed | 2 | 295 | Europe | Ramipril, Firibastat, QGC001 | Quantum Genomics SA | Myocardial Infarction | 07/21 | 07/21 | | |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Aortic Valve Stenosis, Structural Valve Deterioration, Structural Valve Degeneration | 09/25 | 12/26 | | |
MOSAIC-COR, NCT05313919: Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis |
|
|
| Recruiting | N/A | 160 | Europe | Comprehensive functional diagnostics of coronary circulation | Bartlomiej Guzik, Abbott | Coronary Artery Disease, Ischemia and No Obstructive Coronary Arteries, Ischemic Heart Disease, Microvascular Angina, Vasospastic Angina | 12/22 | 06/23 | | |
| Fatica, Richard |
| Terminated | 3 | 667 | Europe, Japan, US, RoW | Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule | Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC | Autosomal Dominant Polycystic Kidney, ADPKD | 08/23 | 08/23 | | |
| Recruiting | 2/3 | 180 | US | Anti-BK polyomavirus (AntiBKV) | Memo Therapeutics AG | BK Viremia; BKV DNAemia | 11/24 | 11/24 | | |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx, Prospera, transplant patient blood sample, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Kidney Transplant Rejection | 12/24 | 12/25 | | |
| Recruiting | N/A | 5000 | US | Prospera | Natera, Inc., University of Maryland | Kidney Transplant Rejection | 10/26 | 10/27 | | |
| LEURENT, GUILLAUME |
TRICURE, NCT05126030: TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First In Human Trial |
|
|
| Recruiting | N/A | 20 | Europe | Topaz TTVR System | TRiCares GmbH | Tricuspid Regurgitation | 04/24 | 05/29 | | |
HighFLO, NCT04888247: Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve |
|
|
| Recruiting | N/A | 30 | Europe, RoW | CLARITY | HighLife SAS | Mitral Regurgitation | 12/24 | 02/30 | | |
NCT04029363: Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk |
|
|
| Recruiting | N/A | 120 | Europe, RoW | HighLife Transcatheter Mitral Valve Replacement | HighLife SAS, ICON plc | Mitral Regurgitation | 03/24 | 06/29 | | |
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study |
|
|
| Recruiting | N/A | 400 | Europe, US, RoW | AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy | Ancora Heart, Inc. | Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy | 06/24 | 12/30 | | |
MITRA-HR, NCT03271762: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery |
|
|
| Recruiting | N/A | 330 | Europe, RoW | percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW, MITRACLIP, cardiac surgery | Nantes University Hospital, Ministère de la Santé, Abbott | Mitral Regurgitation | 03/26 | 05/27 | | |
| Smolka, Grzegorz |
| Recruiting | N/A | 200 | Europe, Canada, US | AVP III | Abbott Medical Devices | Paravalvular Aortic Regurgitation | 07/25 | 06/26 | | |
| Recruiting | N/A | 251 | Europe | Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, ASO or Amplatzer Cribriform Occluder, Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder | Abbott Medical Devices | PFO - Patent Foramen Ovale, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PIVSD - Post Infarct Muscular Ventricular Septal Defect | 09/25 | 10/25 | | |
| Hudec, Martin |
| Active, not recruiting | N/A | 172 | Europe | FFR-guided PCI and TAVI, CABG and SAVR | Maatschap Cardiologie Zwolle, Medtronic | Aortic Stenosis, Multi Vessel Coronary Artery Disease, TAVI, CABG, PCI, Fractional Flow Reserve | 04/24 | 11/24 | | |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
| Piecha, Grzegorz |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx, Prospera, transplant patient blood sample, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Kidney Transplant Rejection | 12/24 | 12/25 | | |
| Fine, Nowell |
REVAD, NCT03356353: Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation |
|
|
| Recruiting | 3 | 24 | Canada | Sildenafil Citrate, Revatio | University of Calgary, Pfizer | End Stage Heart Failure | 09/21 | 01/22 | | |
| Recruiting | N/A | 1500 | Canada | Carotid Contrast Enhanced Ultrasound, Contrast injection, DEFINITY®, Perflutren Lipid Microsphere | Dr. Amer Johri, Lantheus Medical Imaging | Atherosclerosis, Cardiovascular Diseases, Acute Coronary Syndrome, Ischemic Heart Disease, Myocardial Infarction, Carotid Artery Diseases | 08/26 | 08/26 | | |
| Trebacz, n med Jaroslaw |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
| Wojakowski, W |
| Active, not recruiting | N/A | 172 | Europe | FFR-guided PCI and TAVI, CABG and SAVR | Maatschap Cardiologie Zwolle, Medtronic | Aortic Stenosis, Multi Vessel Coronary Artery Disease, TAVI, CABG, PCI, Fractional Flow Reserve | 04/24 | 11/24 | | |
| Parma, Radoslaw |
NCT05844969: Circle Method Observational Project - Non-interventional, Retrospective, Multicenter International Data Collection |
|
|
| Recruiting | N/A | 60 | Europe | | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Aortic Stenosis With Bicuspid Valve | 12/23 | 12/23 | | |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Aortic Valve Stenosis, Structural Valve Deterioration, Structural Valve Degeneration | 09/25 | 12/26 | | |
| Bednarek, Jacek |
| No trials found |
| Ali, Imtiaz |
| No trials found |
| Gocol, Radoslaw |
| No trials found |
| Soteras, Inigo |
| No trials found |
| Rychlik, Agnieszka |
| No trials found |
